Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

FDA Issues Warning About Diabetes Drug

-October 17, 2007 

The FDA recently issued a warning to doctors and patients regarding the use of the diabetes drug Byetta.

The drug was approved in 2005 and is co-marketed by Amylin Pharmaceuticals Inc., and Eli Lilly & Co.

Byetta Linked With Complications

FDA officials say that Byetta has been linked with acute pancreatitis, which can oftentimes be fatal.

According to the agency, 30 post-marketing reports of acute pancreatitis have been associated with the medication.

Amylin Plans to Update Labels

Amylin has reportedly agreed to update Byetta's label to add the risks of pancreatitis.

“It's a rare but serious event,” says Alice Bahner Izzo, spokeswoman for Amylin.

According to reports, 700,000 patients in the U.S. have used Byetta since being introduced.

Risks Associated with Drug

The FDA says that patients and doctors should be cautious with the medication and alert of the symptoms associated with acute pancreatitis.

Some of the symptoms of acute pancreatitis include:

  • Severe abdominal pain that can effect the back
  • Nausea and vomiting
  • Indigestion

The agency says that use of Byetta should be immediately stopped if pancreatitis is suspected.

(Source: The Wall Street Journal)

Have you or someone you know been harmed by Byetta? If so, please contact us today to speak with an experienced attorney who will enable you and your loved ones to be compensated for any injuries.

Contact a News Recall Lawyer